Baclofen Effects on Smoking Urge and Withdrawal
Sponsor: VA Office of Research and Development
Terminated
Enrollment was completed with insufficient sample size for publishable results
Other terminated trials from VA Office of Research and Development
- SCI · Phase EARLY_PHASE1 · Feb 2026
- Spinal Cord Injury · Phase NA · Dec 2025
- Anxiety Disorders · Phase NA · Nov 2025
- Anemia · Phase PHASE2 · Jul 2025
- Early Stage Lung Cancer (I and II) · Phase PHASE2 · Mar 2025
See all terminations from VA Office of Research and Development
Other Nicotine Dependence trials with similar outcome
Listed as NCT00257894, this PHASE2 trial focuses on Nicotine Dependence and Nicotine Use Disorder and remains terminated or withdrawn. Sponsored by VA Office of Research and Development, it has been updated 8 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE2
-
Jan 2021 — Dec 2022 [monthly]
Terminated PHASE2
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE2
First recorded
Dec 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- VA Office of Research and Development
For direct contact, visit the study record on ClinicalTrials.gov .